Laser Photonics Secures $0.5 Million Order for CMS Laser Processing System From Medical Device Manufacturer
Rhea-AI Summary
Laser Photonics (NASDAQ:LASE) announced on January 12, 2026 that it received a new $0.5 million order for a custom CMS Laser processing system from a U.S.-based medical device manufacturer. The system uses a dual-fiber-laser configuration—one laser for marking (annealed marks) and one for selective ablation—to meet exceptionally fast cycle times. The fully automated solution includes bin hopper delivery, dual integrated robots, a rotary table for high-speed throughput, and proprietary software controls. Management said the order underscores momentum in regulated medical and pharmaceutical manufacturing and supports the company’s strategy to build long-term partnerships in regulated end markets.
Positive
- Received a $0.5 million order for a CMS Laser processing system
Negative
- None.
News Market Reaction
On the day this news was published, LASE declined 0.46%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Pre-news, LASE was down while peers showed mixed moves: CVV up 10.05%, LBGJ up 4.29%, CETY modestly higher, and BURU/SPPL lower. This points to stock-specific dynamics rather than a sector-wide shift.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Jan 08 | Conference attendance | Positive | +2.8% | Participation in 2026 Capitol Hill Defense Outlook Summit with defense stakeholders. |
| Jan 07 | Management change | Positive | -0.5% | Appointment of experienced marketing executive to lead global strategy. |
| Jan 05 | Order win | Positive | +13.5% | Initial <b>$500,000</b> order from major U.S. power utility for laser systems. |
| Dec 31 | Compliance update | Positive | +8.3% | Regained compliance with Nasdaq quarterly filing rule after 10-Q submission. |
| Dec 23 | Earnings update | Neutral | +1.9% | Reported Q3 2025 revenue growth with losses, write-down, and Beamer acquisition. |
Recent company-specific news, especially order wins and compliance milestones, has more often coincided with positive price reactions than not, suggesting news flow has been an important driver.
Over the last few weeks, Laser Photonics reported multiple developments. On Dec 23, 2025, Q3 2025 results showed $0.9M revenue, up 28% YoY, but with losses and an inventory write-down. On Dec 31, 2025, it regained compliance with Nasdaq Listing Rule 5250(c)(1), which was followed by a +8.33% move. Early January 2026 brought a $0.5M power-utility order and a marketing leadership hire. Another conference appearance was announced on Jan 8. Today’s new $0.5M medical-device CMS Laser order extends that order-momentum narrative into another regulated end market.
Market Pulse Summary
This announcement adds a $0.5 million CMS Laser order from a U.S. medical device manufacturer to Laser Photonics’ recent string of commercial wins and regulatory updates. It extends the company’s reach in regulated markets alongside a similar-sized power-utility order. Investors may contextualize this against the latest 10-Q, which reported strong revenue growth but wider losses and going-concern disclosure, making ongoing order flow and margin trends key metrics to watch.
Key Terms
fiber lasers technical
ablation medical
rotary table technical
AI-generated analysis. Not financial advice.
ORLANDO, FL / ACCESS Newswire / January 12, 2026 / Laser Photonics Corporation (NASDAQ:LASE), a global leader in laser systems for industrial and defense applications, today announced that it has received a new
Custom-designed for the application, the CMS Laser system features two fiber lasers - one dedicated to marking and the other to ablation of the metal components used for medical purposes. The marking process creates annealed marks, while selective ablation textures a section of the components. Operating in parallel, the dual-laser configuration is designed to meet the manufacturer's exceptionally fast cycle times.
The fully automated setup includes bin hopper delivery, dual integrated robots for part transport and precise positioning, and a rotary table for high-speed multiple part throughput. The system operates using Laser Photonic's proprietary software controls.
Wayne Tupuola, Chief Executive Officer of Laser Photonics, commented: "This CMS Laser order reflects our growing momentum in highly regulated manufacturing, where precision, reliability, and validation standards are critical. Medical device and pharmaceutical customers demand systems that deliver high performance and integrate seamlessly into automated production lines, and our fully automated, dual-laser configuration highlights the strength of our engineering platform and understanding of mission-critical workflows. As demand rises for cleaner, more efficient alternatives to legacy processes, this order reinforces our strategy to build long-term partnerships in regulated end markets."
About Laser Photonics Corporation
Laser Photonics Corporation (NASDAQ: LASE) is a global leader in laser systems for industrial and defense applications. The Company develops and manufactures advanced laser technologies used in cleaning, surface preparation, and precision material processing across demanding operating environments. Laser Photonics serves a broad range of end markets, including defense and government, aerospace, energy, maritime, automotive, and advanced manufacturing. Through a combination of internal development, strategic acquisitions, and partnerships, the Company continues to expand its product portfolio and address new applications where performance, efficiency, and environmental considerations are critical. For more information, please visit https://laserphotonics.com.
Cautionary Note Concerning Forward-Looking Statements
This press release contains forward-looking statements within the meaning of applicable securities laws. These statements are based on current expectations as of the date of this press release and involve risks and uncertainties that may cause results and uses of proceeds to differ materially from those indicated by these forward-looking statements. We encourage readers to review the "Risk Factors" in our Registration Statement for a comprehensive understanding. Laser Photonics Corp. undertakes no obligation to revise or update any forward-looking statements, except as required by applicable laws or regulations, to reflect events or circumstances after the date of this press release.
Investor Relations Contact
Lucas A. Zimmerman & Ian Scargill
MZ Group - MZ North America
(262) 357-2918
LASE@mzgroup.us
www.mzgroup.us
SOURCE: Laser Photonics Corp.
View the original press release on ACCESS Newswire
FAQ
What did Laser Photonics (LASE) announce on January 12, 2026?
What features does the CMS Laser system ordered by LASE include?
How does the LASE CMS Laser system meet the medical manufacturer's production needs?
Which markets does Laser Photonics say this order supports for LASE?
Will the CMS Laser system from LASE integrate into automated production lines?
